Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|15|1879-1894

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.15, 2006-05, pp. : 1879-1894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1- Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview

By  

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1874-1898

Bentham Science Publishers

Access to resources Recommend Favorite

Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

By  

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3335-3342

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 921-944

Bentham Science Publishers

Access to resources Recommend Favorite

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E.   Paterson Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite